Results 241 to 250 of about 213,434 (307)

Immunohistochemical expression of CD57 in different histopathological grades of oral squamous cell carcinoma. [PDF]

J Oral Maxillofac Pathol
Rathipriya A, Ramesh M, Prem D, Sakthivel VS, Murugesan A, Varrshana V.   +5 more
europepmc   +1 more source

Oral Health—Head and Neck Cancers: Addressing Confounding Through Negative Control and Quantitative Bias Analyses

Community Dentistry and Oral Epidemiology, EarlyView.
ABSTRACT Objectives While there are plausible biological explanations for the association between oral health and head and neck cancers (HNC), existing studies have yielded conflicting results. A key concern is that these associations are influenced by mediators, unmeasured risk factors, and biases. To address this, a negative control exposure was used
P. K. Elango, B. Nicolau, N. Farsi, A. V. Grant, M. C. Rousseau, S. Madathil   +5 more
wiley   +1 more source

Serum metabolomics reveals distinctive signature of cancer staging in oral squamous cell carcinoma. [PDF]

BMC Oral Health
Lu W, Liu L, Li J, Yang H, Yang Y, Hu Q, Song X, Liu L, Yang X.   +8 more
europepmc   +1 more source

Verruciform Xanthoma Within the Cyst Lining of Hidradenitis Suppurativa

Journal of Cutaneous Pathology, EarlyView.
ABSTRACT Verruciform xanthoma (VX) is a rare lesion most often seen in the oral mucosa or anogenital region, most commonly characterized histologically by verrucous epithelial hyperplasia and foamy histiocytes in the papillary dermis. While VX has been reported in association with inflammatory dermatoses such as lichen planus and lichen sclerosus, its ...
Deaquan Nichols, Aref Moshayedi, Ja Hea Gu, David M. Milgraum, Mark C. Mochel   +4 more
wiley   +1 more source

Downregulation of PDIA4 inhibits proliferation and migration in human oral squamous cell carcinoma. [PDF]

Hereditas
Hu Y, Zhang W, Zhang F, Liu Q, Yang H.
europepmc   +1 more source

Bispecific Dual‐Immune Checkpoint Inhibitor Associated Cutaneous Toxicity: A Report of Lorigerlimab Adverse Skin Reaction in Two Cancer Patients

Journal of Cutaneous Pathology, EarlyView.
ABSTRACT Lorigerlimab is a dual bispecific antibody (BsAb) targeting cytotoxic T‐lymphocyte‐associated protein 4 and programmed cell death protein 1 that is used for treatment of advanced solid cancers such as metastatic castration‐resistant prostate carcinoma.
Niloofar Sina, Fiorinda Muhaj, Volha Lenskaya, Doina Ivan, Victor G. Prieto, Jonathan L. Curry   +5 more
wiley   +1 more source

Vitamin D status in patients with oral leukoplakia and oral squamous cell carcinoma: a systematic review and meta-analysis. [PDF]

BMC Oral Health
Liu J, Li R, Zhang Y, Tan H, Sun Y, Liu Y.   +5 more
europepmc   +1 more source

Oral squamous cell carcinoma: Advances in management

Indian Journal of Dental Research, 2015
openaire   +3 more sources

Long‐term disease control of disseminated superficial actinic porokeratosis (DSAP) with simvastatin 2%/ cholesterol 2% cream

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Introduction Disseminated superficial actinic porokeratosis (DSAP) is a rare keratinization disorder associated with an increased risk of cutaneous tumors. Objectives To develop a feasible and easy‐to‐apply treatment regimen for long‐time disease control of DSAP including prevention of new skin tumors. Patients and Methods 19 patients with DSAP
Berenice M. Lang, Gregor Ojak, Mandy Crummenauer, Joanna Wegner, Caroline Mann, Stephan Grabbe, Petra Staubach   +6 more
wiley   +1 more source

Trends in immunotherapy for oral squamous cell carcinoma. [PDF]

Cell Oncol (Dordr)
Xue N, Wang Y, Wang Z, Zeng X, Wang J, Zhang X.   +5 more
europepmc   +1 more source